Nanobiotix S.A. ( NBTX) - Key Metrics
NBTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.11 | -$0.71 | -$0.46 | -$0.47 |
| 2025Q4 | $0.06 | -$0.39 | -$0.33 | -$0.34 |
| 2025Q2 | $0.56 | -$0.11 | -$0.37 | -$0.37 |
| 2024Q4 | -$0.35 | -$0.98 | -$0.29 | -$0.30 |
| 2024Q2 | $0.20 | -$0.46 | -$0.12 | -$0.13 |
NBTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -11.62 |
| 2025Q4 | 0% | -12.61 |
| 2025Q2 | 0% | -9.12 |
| 2024Q4 | 0% | -0.71 |
| 2024Q2 | 0% | -2.71 |
NBTX
Price: $22.58
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.23 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: France
Volume: 700
Market Capitalization: 1.3 billion